Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

• 收藏
• 分享

专利权人:

Celgene Corporation

发明人:

Hui, Ho-Wah,Pu, Yu

申请号：

AU2017205167

公开号：

AU2017205167A1

申请日:

2017.01.06

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Provided herein are lyophilized formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide or a stereisomer or mixture of stereisomers, pharmaceutically acceptable salt, tautomer, prodrug, solvate, hydrate, co-crystal, clathrate, or polymorph thereof. Methods of using the formulations and dosage forms for treating, managing, and/or preventing cancer are also provided herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/